Honz Pharmaceutical Co., Ltd. (300086.SZ)
CNY 4.36
(3.32%)
CNY 4.36
(3.32%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 11.52 Million CNY | 106.15% |
| 2022 | -187.58 Million CNY | -1807.25% |
| 2021 | 10.98 Million CNY | 17.65% |
| 2020 | 9.33 Million CNY | 135.29% |
| 2019 | -26.46 Million CNY | -297.98% |
| 2018 | 13.36 Million CNY | -73.37% |
| 2017 | 50.19 Million CNY | 8.75% |
| 2016 | 46.15 Million CNY | -32.43% |
| 2015 | 68.31 Million CNY | 10.02% |
| 2014 | 62.09 Million CNY | 318.05% |
| 2013 | 14.85 Million CNY | -34.22% |
| 2012 | 22.58 Million CNY | 2085.72% |
| 2011 | -1.13 Million CNY | -100.82% |
| 2010 | 139.31 Million CNY | 42.78% |
| 2009 | 97.57 Million CNY | 97.03% |
| 2008 | 49.52 Million CNY | 44.82% |
| 2007 | 34.19 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -54.35 Million CNY | -16.89% |
| 2024 Q1 | -46.5 Million CNY | -245.41% |
| 2024 Q3 | -21.86 Million CNY | 59.77% |
| 2023 Q2 | 896.69 Thousand CNY | -94.18% |
| 2023 Q1 | 15.41 Million CNY | 119.77% |
| 2023 Q4 | 31.98 Million CNY | 186.99% |
| 2023 Q3 | -36.76 Million CNY | -4199.93% |
| 2023 FY | 11.52 Million CNY | 106.15% |
| 2022 Q1 | -46.23 Million CNY | -187.92% |
| 2022 FY | -187.58 Million CNY | -1807.25% |
| 2022 Q4 | -77.97 Million CNY | -257.04% |
| 2022 Q3 | -21.83 Million CNY | 47.41% |
| 2022 Q2 | -41.53 Million CNY | 10.19% |
| 2021 Q4 | 52.59 Million CNY | 228.06% |
| 2021 Q3 | 16.03 Million CNY | 157.75% |
| 2021 Q1 | -29.87 Million CNY | -514.67% |
| 2021 Q2 | -27.75 Million CNY | 7.09% |
| 2021 FY | 10.98 Million CNY | 17.65% |
| 2020 FY | 9.33 Million CNY | 135.29% |
| 2020 Q2 | 18.91 Million CNY | 264.98% |
| 2020 Q3 | -5.31 Million CNY | -128.1% |
| 2020 Q4 | 7.2 Million CNY | 235.53% |
| 2020 Q1 | -11.46 Million CNY | 59.22% |
| 2019 Q2 | -20.75 Million CNY | -176.53% |
| 2019 FY | -26.46 Million CNY | -297.98% |
| 2019 Q1 | 27.12 Million CNY | 184.5% |
| 2019 Q4 | -28.12 Million CNY | -497.16% |
| 2019 Q3 | -4.7 Million CNY | 77.31% |
| 2018 Q1 | 20.18 Million CNY | 124.93% |
| 2018 Q3 | 9.23 Million CNY | -42.48% |
| 2018 FY | 13.36 Million CNY | -73.37% |
| 2018 Q4 | -32.09 Million CNY | -447.68% |
| 2018 Q2 | 16.04 Million CNY | -20.48% |
| 2017 Q4 | 8.97 Million CNY | -4.38% |
| 2017 FY | 50.19 Million CNY | 8.75% |
| 2017 Q1 | 15.02 Million CNY | 12.9% |
| 2017 Q2 | 16.81 Million CNY | 11.87% |
| 2017 Q3 | 9.38 Million CNY | -44.19% |
| 2016 Q3 | 8.8 Million CNY | 54.54% |
| 2016 Q4 | 13.31 Million CNY | 51.24% |
| 2016 Q1 | 18.34 Million CNY | -50.8% |
| 2016 FY | 46.15 Million CNY | -32.43% |
| 2016 Q2 | 5.69 Million CNY | -68.96% |
| 2015 Q2 | 25.53 Million CNY | 476.27% |
| 2015 Q4 | 37.29 Million CNY | 203.87% |
| 2015 Q3 | 12.27 Million CNY | -51.94% |
| 2015 FY | 68.31 Million CNY | 10.02% |
| 2015 Q1 | -6.78 Million CNY | -126.19% |
| 2014 Q4 | 25.91 Million CNY | 88.91% |
| 2014 Q3 | 13.71 Million CNY | 10.65% |
| 2014 Q2 | 12.39 Million CNY | 23.22% |
| 2014 Q1 | 10.06 Million CNY | 282.05% |
| 2014 FY | 62.09 Million CNY | 318.05% |
| 2013 Q2 | 10.84 Million CNY | 88.89% |
| 2013 FY | 14.85 Million CNY | -34.22% |
| 2013 Q4 | -5.52 Million CNY | -245.82% |
| 2013 Q3 | 3.79 Million CNY | -65.06% |
| 2013 Q1 | 5.74 Million CNY | 6.93% |
| 2012 Q4 | 5.37 Million CNY | -54.16% |
| 2012 Q2 | 2.93 Million CNY | 14.9% |
| 2012 Q3 | 11.71 Million CNY | 298.8% |
| 2012 Q1 | 2.55 Million CNY | 125.13% |
| 2012 FY | 22.58 Million CNY | 2085.72% |
| 2011 Q3 | -3.55 Million CNY | -356.01% |
| 2011 Q4 | -10.17 Million CNY | -186.06% |
| 2011 FY | -1.13 Million CNY | -100.82% |
| 2011 Q1 | 11.2 Million CNY | -75.03% |
| 2011 Q2 | 1.38 Million CNY | -87.6% |
| 2010 Q3 | 40.1 Million CNY | 36.72% |
| 2010 Q2 | 29.33 Million CNY | 17.28% |
| 2010 FY | 139.31 Million CNY | 42.78% |
| 2010 Q1 | 25.01 Million CNY | -8.72% |
| 2010 Q4 | 44.86 Million CNY | 11.86% |
| 2009 Q2 | 18.26 Million CNY | 38.47% |
| 2009 FY | 97.57 Million CNY | 97.03% |
| 2009 Q1 | 13.19 Million CNY | 0.0% |
| 2009 Q4 | 27.39 Million CNY | -29.22% |
| 2009 Q3 | 38.71 Million CNY | 111.9% |
| 2008 FY | 49.52 Million CNY | 44.82% |
| 2007 FY | 34.19 Million CNY | 0.0% |